Frank Litvack

CAPR

Frank Litvack serves as Director at Capricor Therapeutics, Inc. (CAPR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$297.9K

Net Position

Net Seller

$297.9K

Companies Traded

CAPR

Active Period

Jan 2022 – Mar 2025

4 total trades

Most Recent

Sell CAPR

Mar 3, 2025 · $34.8K

Frank Litvack's Insider Trading at Capricor Therapeutics, Inc. (CAPR)

Buys

0 · $0.00

Sells

4 · $297.9K

Total Shares Bought

Total Shares Sold

78,983

CAPR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 3, 2025	Sell	2,543	$13.67	$34.8K
Aug 14, 2023	Sell	4,364	$6.61	$28.8K
Feb 21, 2023	Sell	4,524	$4.31	$19.5K
Jan 3, 2022	Sell	67,552	$3.18	$214.8K

Related Insiders

Anthony Bergmann

officer: CHIEF FINANCIAL OFFICER

CAPRSell · Apr 1, 2026

Karen Krasney

officer: EVP, GENERAL COUNSEL

CAPRSell · Apr 1, 2026

Karimah Es Sabar

director

CAPRSell · Apr 1, 2026

Explore More Insider Trading Data

CAPR Insider Trading Activity

View all insider trades at Capricor Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity